Atrial Flutter
Atrial Flutter
Atrial flutter is a reentrant supraventricular tachycardia with regular atrial activity at 250–350 bpm, typically with 2:1 or 4:1 AV block.
Latest evidence
Mechanisms and Advances in the Treatment of Arrhythmias Associated With Pulmonary Hypertension.
Impact of Early Atrial Tachyarrhythmia Within the Blanking Period on Late Recurrence After Pulsed Field Ablation of Atrial Fibrillation.
Racial and Ethnic Disparities in the Utilization and Outcomes of Catheter Ablation for Atrial Fibrillation and Flutter: a State-of-the-Art Review.
Pulmonary Vein Isolation Alone Versus Adjunctive Ablation for Paroxysmal Atrial Fibrillation.
What this condition is
What is an arrhythmia?An arrhythmia is a problem with the rate or rhythm of your heartbeat. Your heart beats too quickly, too slowly, or with an irregular pattern. Changes in the electrical signals that control your heartbeat cause arrhythmias.When your heart beats faster than normal, it's called tachycardia.When your heart beats too slowly, it's called bradycardia.When the signal to beat comes too early, it's calle…
Open official source →Terms and documentation support
Condition matches & synonyms
TermsRelated diagnostic names, synonyms, and documentation wording that may appear in clinical references and charting.
ICD-10 quick links
CodesFor study support, terminology recognition, and documentation language.
Tests performed
Recognize the drug and the class
NANDA diagnoses & care plans
Use these direct links to open nursing diagnoses and care-plan support related to Atrial Flutter.
Additional official research
The MAGiC™ Cardiac Ablation European Study
The purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval. The purpose of MAGiC-FEST PMCF Study is to collect safety and performance data with MAGiC to…
An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia
This is a prospective, single-group clinical study. The objective is to evaluate the safety and efficacy of focal pulse ablation system in the treatment of typical atrial flutter.
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
VISIONAIRE (Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE) trial will be a prospective randomized open-label with blinded endpoint adjudication trial including 1500 patient…
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
The MODIFY CSX study is a prospective, randomized, placebo-controlled trial conducted in heart centers in Germany and Italy. A total of 550 high-risk cardiac surgery patients will receive either 0.20 g fish oil/kg body weight (BW) + standa…
HeartBeam ECG Registry
The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.
Get With the Guidelines Atrial Fibrillation Registry
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of A…
Anatomical Navigation for Guided Electrophysiology in AFL and AFib
The objective of the study is to collect data on the use of the VERAFEYE Anatomical Guidance System in adult patients indicated to undergo a catheter ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or pers…
Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.
Plain-language study support
Useful for plain-language reinforcement and quick review.